Cargando…

Clinical Significance of Glycolytic Metabolic Activity in Hepatocellular Carcinoma

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is among the most common cancers and causes about 830,000 deaths annually in the world. Metabolic reprogramming is a critical hallmark of HCC, enabling HCC cells to adapt to the high energy demands necessary for fast growth. However, the clinical releva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Joann, Park, Sowon, Jang, Yeonwoo, Lee, Sung-Hwan, Jeong, Yun Seong, Yim, Sun Young, Lee, Ju-Seog
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818850/ https://www.ncbi.nlm.nih.gov/pubmed/36612182 http://dx.doi.org/10.3390/cancers15010186

Ejemplares similares

Clinical significance of APOB inactivation in hepatocellular carcinoma
por: Lee, Gena, et al.
Publicado: (2018)

Two distinct stem cell‐like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentials
por: Lee, Sung Hwan, et al.
Publicado: (2022)

An Overview of the Genomic Characterization of Hepatocellular Carcinoma
por: Yim, Sun Young, et al.
Publicado: (2021)

Low ARID1A Expression is Associated with Poor Prognosis in Hepatocellular Carcinoma
por: Yim, Sun Young, et al.
Publicado: (2020)

Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma
por: Jiang, Jianwen, et al.
Publicado: (2020)

METTL3 expression is associated with glycolysis metabolism and sensitivity to glycolytic stress in hepatocellular carcinoma
por: Lin, Ye, et al.
Publicado: (2020)

Clinical significance of YAP1 activation in head and neck squamous cell carcinoma
por: Eun, Young-Gyu, et al.
Publicado: (2017)

Clinical significance of radiation-induced liver disease after stereotactic body radiation therapy for hepatocellular carcinoma
por: Jun, Baek Gyu, et al.
Publicado: (2018)

The Clinicopathological and Prognostic Significance of the Gross Classification of Hepatocellular Carcinoma
por: Lee, Yangkyu, et al.
Publicado: (2018)

Silencing the Girdin gene enhances radio-sensitivity of hepatocellular carcinoma via suppression of glycolytic metabolism
por: Yu, Li, et al.
Publicado: (2017)

Ezrin promotes hepatocellular carcinoma progression by modulating glycolytic reprogramming
por: Wang, Xinyue, et al.
Publicado: (2020)

Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma
por: Lu, Chenying, et al.
Publicado: (2020)

Glutamine synthetase mediates sorafenib sensitivity in β-catenin-active hepatocellular carcinoma cells
por: Sohn, Bo Hwa, et al.
Publicado: (2018)

The Glycolytic Phenotype is Correlated with Aggressiveness and Poor Prognosis in Invasive Ductal Carcinomas
por: Jang, Se Min, et al.
Publicado: (2012)

The mutational landscape of hepatocellular carcinoma
por: Lee, Ju-Seog
Publicado: (2015)

Multi-omic analysis of glycolytic signatures: exploring the predictive significance of heterogeneity and stemness in immunotherapy response and outcomes in hepatocellular carcinoma
por: Zhang, Shiyu, et al.
Publicado: (2023)

Correction to: Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma
por: Lu, Chenying, et al.
Publicado: (2020)

PFKFB3-mediated Pro-glycolytic Shift in Hepatocellular Carcinoma Proliferation
por: Dou, Qianhui, et al.
Publicado: (2022)

Anti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options
por: Pourbaghi, Miles, et al.
Publicado: (2023)

Cell line-specific features of 3D chromatin organization in hepatocellular carcinoma
por: Kim, Yeonwoo, et al.
Publicado: (2023)

The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition
por: Goodwin, Justin, et al.
Publicado: (2017)

EGF receptor stimulation shifts breast cancer cell glucose metabolism toward glycolytic flux through PI3 kinase signaling
por: Jung, Kyung-Ho, et al.
Publicado: (2019)

Extracellular Citrate Treatment Induces HIF1α Degradation and Inhibits the Growth of Low-Glycolytic Hepatocellular Carcinoma under Hypoxia
por: Kim, Seon Yoo, et al.
Publicado: (2022)

Significance of TERT Genetic Alterations and Telomere Length in Hepatocellular Carcinoma
por: Jang, Jeong-Won, et al.
Publicado: (2021)

Predictive Value of Antiviral Effects in the Development of Hepatocellular Carcinoma in the General Korean Population with Chronic Hepatitis B
por: Shim, Jae-Jun, et al.
Publicado: (2016)

PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinoma
por: Lu, Li-Gong, et al.
Publicado: (2022)

Therapeutic Potential of (−)-Agelamide D, a Diterpene Alkaloid from the Marine Sponge Agelas sp., as a Natural Radiosensitizer in Hepatocellular Carcinoma Models
por: Choi, Changhoon, et al.
Publicado: (2020)

Clinical significance of lncRNA-ATB expression in human hepatocellular carcinoma
por: Jang, Se Young, et al.
Publicado: (2017)

Phosphoglycerate Mutase 1: Its Glycolytic and Non-Glycolytic Roles in Tumor Malignant Behaviors and Potential Therapeutic Significance
por: Li, Na, et al.
Publicado: (2020)

Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma
por: Lee, Sang Soo, et al.
Publicado: (2013)

Metastatic hepatocellular carcinoma presenting as facial nerve palsy and facial pain
por: Yang, Jong In, et al.
Publicado: (2011)

Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis
por: Martins, Sandra Fernandes, et al.
Publicado: (2016)

miR-592/WSB1/HIF-1α axis inhibits glycolytic metabolism to decrease hepatocellular carcinoma growth
por: Jia, Yan-Yan, et al.
Publicado: (2016)

Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122
por: Song, Kyoungsub, et al.
Publicado: (2015)

Differential Effect of HCV Eradication and Fibrosis Grade on Hepatocellular Carcinoma and All-cause Mortality
por: Lee, Yun Bin, et al.
Publicado: (2018)

Risk Factors of Cryptogenic Hepatocellular Carcinoma in Patients with Low Body Mass Index or without Metabolic Syndrome
por: Song, Hwa Young, et al.
Publicado: (2012)

Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma
por: Sung, Jong Jin, et al.
Publicado: (2016)

AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma
por: Kwon, Jung-Hee, et al.
Publicado: (2015)

Significance of exosomes in hepatocellular carcinoma
por: Wang, GuoYun, et al.
Publicado: (2022)

Current status of ultrasonography in national cancer surveillance program for hepatocellular carcinoma in South Korea: a large-scale multicenter study
por: Yoo, Sun Hong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_48lneu1jbah2k6hi2rgmn653c6